Search research articles
Contact Us
Filters
Showing results (1-10 of 37) with videos related to
Page
of 4
Sort By:
Biology
|
March 29, 2023
Effective Reversal of Macrophage Polarization by Inhibitory Combinations Predicted by a Boolean Protein-Protein Interaction Model
Gabor Szegvari, David Dora, Zoltan Lohinai
Translational Oncology
|
September 3, 2019
Next-Generation Sequencing May Discriminate Extreme Long-term versus Short-term Survival in Patients with Metastatic Small Cell Lung Cancer (SCLC)
Zoltan Lohinai, Zsolt Megyesfalvi, Balazs Dome, et al.
Biodata Mining
|
October 1, 2022
EZCancerTarget: an open-access drug repurposing and data-collection tool to enhance target validation and optimize international research efforts against highly progressive cancers
David Dora, Timea Dora, Gabor Szegvari, et al.
Frontiers in Medicine
|
December 16, 2024
Predicting cancer-related mycobiome aspects in gastrointestinal cancers: a systematic review
György Szklenarik, Peter Kiraly, Gabor Szegvari, et al.
Journal of Translational Medicine
|
July 8, 2025
Gut microbiome changes and cancer immunotherapy outcomes associated with dietary interventions: a systematic review of preclinical and clinical evidence
Csenge Somodi, David Dora, Mátyás Horváth, et al.
International Journal of Molecular Sciences
|
July 12, 2025
Predicting Immunotherapy Efficacy with Machine Learning in Gastrointestinal Cancers: A Systematic Review and Meta-Analysis
Sara Szincsak, Péter Király, Gabor Szegvari, et al.
Journal of Translational Medicine
|
November 20, 2024
Gut metatranscriptomics based de novo assembly reveals microbial signatures predicting immunotherapy outcomes in non-small cell lung cancer
David Dora, Peter Kiraly, Csenge Somodi, et al.
Translational Lung Cancer Research
|
February 10, 2023
BRAF RNA is prognostic and widely expressed in lung adenocarcinoma
David Dora, Imre Vörös, Zoltán V Varga, et al.
Frontiers in Cellular and Infection Microbiology
|
December 5, 2024
Metabolic pathways from the gut metatranscriptome are associated with COPD and respiratory function in lung cancer patients
David Dora, Peter Revisnyei, Anna Mihucz, et al.
Plos One
|
January 7, 2016
From Bench to Bedside: Attempt to Evaluate Repositioning of Drugs in the Treatment of Metastatic Small Cell Lung Cancer (SCLC)
Zoltan Lohinai, Peter Dome, Zsuzsa Szilagyi, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 37) with videos related to
Sort By:
Page
of 4
Biology
|
March 29, 2023
Effective Reversal of Macrophage Polarization by Inhibitory Combinations Predicted by a Boolean Protein-Protein Interaction Model
Gabor Szegvari, David Dora, Zoltan Lohinai
Translational Oncology
|
September 3, 2019
Next-Generation Sequencing May Discriminate Extreme Long-term versus Short-term Survival in Patients with Metastatic Small Cell Lung Cancer (SCLC)
Zoltan Lohinai, Zsolt Megyesfalvi, Balazs Dome, et al.
Biodata Mining
|
October 1, 2022
EZCancerTarget: an open-access drug repurposing and data-collection tool to enhance target validation and optimize international research efforts against highly progressive cancers
David Dora, Timea Dora, Gabor Szegvari, et al.
Frontiers in Medicine
|
December 16, 2024
Predicting cancer-related mycobiome aspects in gastrointestinal cancers: a systematic review
György Szklenarik, Peter Kiraly, Gabor Szegvari, et al.
Journal of Translational Medicine
|
July 8, 2025
Gut microbiome changes and cancer immunotherapy outcomes associated with dietary interventions: a systematic review of preclinical and clinical evidence
Csenge Somodi, David Dora, Mátyás Horváth, et al.
International Journal of Molecular Sciences
|
July 12, 2025
Predicting Immunotherapy Efficacy with Machine Learning in Gastrointestinal Cancers: A Systematic Review and Meta-Analysis
Sara Szincsak, Péter Király, Gabor Szegvari, et al.
Journal of Translational Medicine
|
November 20, 2024
Gut metatranscriptomics based de novo assembly reveals microbial signatures predicting immunotherapy outcomes in non-small cell lung cancer
David Dora, Peter Kiraly, Csenge Somodi, et al.
Translational Lung Cancer Research
|
February 10, 2023
BRAF RNA is prognostic and widely expressed in lung adenocarcinoma
David Dora, Imre Vörös, Zoltán V Varga, et al.
Frontiers in Cellular and Infection Microbiology
|
December 5, 2024
Metabolic pathways from the gut metatranscriptome are associated with COPD and respiratory function in lung cancer patients
David Dora, Peter Revisnyei, Anna Mihucz, et al.
Plos One
|
January 7, 2016
From Bench to Bedside: Attempt to Evaluate Repositioning of Drugs in the Treatment of Metastatic Small Cell Lung Cancer (SCLC)
Zoltan Lohinai, Peter Dome, Zsuzsa Szilagyi, et al.
Page
of 4